Worth reading
65In focus
Scored from 3 of 5 sectionsDirection
Improvement
Direction inferred from the company’s description.Scale
24466104
SharesWording
Conditional
How definitive the wording is.This transaction
This tender offerDisclosing companyMEDIPAL HOLDINGS CORPORATION
The voting-rights ratio is the share of the votes exercisable at a shareholders’ meeting that will be held after this transaction.
Date of board resolution11 May 2026
Consideration and expenses
Type of ConsiderationCash
Tender offer price¥6,650 per common share
Minimum number of shares to be purchased8,676,100 shares
Tender offer period12 May 2026 to 7 July 2026 (41 business days)
Procedures and assumptions
Management structure after acquisitionA squeeze-out procedure is planned to make the tender offeror the sole shareholder of the target company. If the squeeze-out procedure is carried out, the target company's shares are expected to be delisted. The company name, representative, and treatment of employees are Not disclosed
| Item | Details |
|---|---|
| Transaction name | This tender offer |
| Name of the Subject Company | PALTAC CORPORATION |
| Type of Consideration | Cash |
| Tender offer price | ¥6,650 per common share |
| Minimum number of shares to be purchased | 8,676,100 shares |
| Tender offer period | 12 May 2026 to 7 July 2026 (41 business days) |
| Number of shares acquired | 24,466,104 shares; the number of voting rights attached to the acquired shares is not stated |
| Voting rights ownership percentage | Before 52.40％ → after 92.64％ |
| Date of board resolution | 11 May 2026 |
| Management structure after acquisition | A squeeze-out procedure is planned to make the tender offeror the sole shareholder of the target company. If the squeeze-out procedure is carried out, the target company's shares are expected to be delisted. The company name, representative, and treatment of employees are Not disclosed |
Items this document does not state (22)
Counterparty nameBusiness Description of the Subject CompanyLocation of the Subject CompanyCapital Stock of the Subject CompanyDate of Establishment of the Subject CompanyNet Sales of the Subject CompanyOperating Profit of the Subject CompanyNet Income of the Subject CompanyNet Assets of the Subject CompanyAcquisition priceExpenses other than the acquisition priceMerger ratio/share exchange ratioFunding arrangementsGoodwill amountAmount of extraordinary income (loss)Impact on Business PerformanceContract DateExecution Date / Effective DateValuation methodologyIndependent valuation institutionSpecial CommitteeConditions Precedent to Execution
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.A squeeze-out procedure is planned to make the tender offeror the sole shareholder of the target company.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.